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Abstract. Study Objective: To study a clinical features of
patient presented with severe hydramnios, associated with
hydronephrosis, that was antenatally diagnosed and has
been successfully treated immediately after birth. At a mo-
lecular level, we investigated the gene expression of key
steroidogenic enzymes from the maternal ovary.
Design: Ultrasound scan,MRI, semi-quantitativeRT-PCR
Setting: The patient was admitted to the University Hos-
pital, University of Crete, Medical School, Greece, where
all clinical data has been obtained. Gene expression studies
took place at Biosciences, Brunel University, UK.
Results: Semi-quantitative RT-PCR analyses revealed
that there is upregulation of key steroidogenic genes in
the maternal ovary, including steroidogenic acute regula-
tory protein, and the cytochrome P450 heme-containing
proteins CYP11A, CYP17 and CYP19. From a clinical per-
spective, the prenatal ultrasound scan and MRI findings
showed a multicystic pelvic mass, bilateral hydronephrosis
and prior to delivery severe polyhydramnios.
Conclusion: This clinical case is the only one that we
have found in the current literature where congenital imper-
forate hymen accompanied with hematocolpos is associated
with renal obstruction in combination with polyhydramnios
and increase in maternal steroidogenic enzymes.O 116117
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Congenital imperforate hymen is the most frequent
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Rwhere mucus and blood from endometrial sloughingaccumulate in the vagina.1 When presented in adults,
there is a distension of the vaginal canal that can lead
to cervical dilation and formation of a hematometra
and hematosalpinx. Symptoms in adults include cy-
clic and abdominal pain, amenorrhea, and difficulty
with urination.2 Retrograde menstruation, i.e., back-
ward menstruation into the peritoneal cavity, can lead
to the onset of endometriosis.
Endometriosis is a clinical and pathological entity
that is characterized by the presence of tissue that re-
sembles functioning endometrial glands and stroma
outside the uterine cavity. Symptoms include infertil-
ity and chronic pelvic pain.3 It has been hypothesized
that vaginal secretions accumulate in response to cir-
culating maternal estrogens.4 Interestingly, recent
clinical and laboratory studies support the concept
that endometriosis is an estrogen-dependent condi-
tion. Indeed, high estradiol concentrations have been
identified as a requisite for proliferation of endometri-
otic lesions, and inducement of a hypoestrogenic state
is a current therapeutic approach.5
To the best of our knowledge, hydrocolpos (cystic
dilatation of the vagina) as an isolated prenatal finding
has only been reported twice previously.6,7 Vaginal
obstruction may be characterized by the sole presence
of an imperforate hymen, a transverse vaginal septum,
or by the presence of a urogenital sinus or cloacal
malformation.8 Imperforate hymen is the result of
the failure of canalization of the vaginal plate,1 which
is formed in part of the Mu¨llerian ducts and from the
urogenital sinus.8 A rare condition of congenital im-
perforate hymen has been presented in which obstruc-
tion of the vagina was associated with accumulation
of uterovaginal secretions produced under circulating
maternal estrogen stimulation, and the development
of a hydrometrocolpos. Large hematocolpos may lead1083-3188/09/$36.00
doi:10.1016/j.jpag.2009.10.002
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to secondary oligoamniosis, due to renal obstruction
and deteriorating renal function. Interestingly, an
adult case of hematocolpos was a consequence of
radiotherapy for cervix carcinoma.9 Moreover, in a re-
cent study of a 15-year-old girl with imperforate
hymen with hematocolpometra, the serum tumor
marker CA125 was elevated.10
This particular clinical case is the only that we have
found in the current literature in which congenital
imperforate hymen accompanied with hydrocolpos is
associated with renal obstruction in combination with
polyhydramnios and increase in key steroidogenic
components of the maternal ovary.
Methods
Ovarian Samples
The sample used in this clinical case was obtained
during cesarean section surgery, due to the presence
of a cyst. Therefore, apart from the cyst, an ovarian
biopsy was also obtained from surface to clarify the
nature of the cyst. The ovarian biopsy was taken with
scissors and there was no significant bleeding. All
control women were age matched, undergoing cesar-
ean section, and there was a presence of ovarian cysts.
For this study, maternal informed consent was ob-
tained after the procedure was fully explained. All
procedures followed were in accordance with the eth-
ical standards of the responsible institutional commit-
tee on human experimentation. Ovarian samples
(n5 4; 1 from the clinical case and 3 pooled controls)
were placed in RNAlater (Sigma Aldrich, UK) until
further use.
RNA Isolation and cDNA Synthesis
Each sample was lysed in 600 ml of RNA lysis buffer
using the TissueLyser (Qiagen, UK). Total RNA was
extracted from these specimens using an RNA extrac-
tion kit (Sigma, UK), according to manufacturer’s in-
structions. RNA concentration was determined by
spectrophotometric analysis (NanoDrop, Thermo Sci-
entific,UK). RNA (200ng)was reverse-transcribed into
cDNA using 5 IU/ml RNase H reverse transcriptase
(Invitrogen, UK).
Semiquantitative RT-PCR
PCR amplification was carried out using Taq poly-
merase (Invitrogen). The primers used for this
study were: steroidogenic acute regulatory protein
(StAR, 181 bp): 5’-CGTGACTTTGTGAGCG-3’ and
5’-GCCACGTAAGTTTGGT-3’; CYP11A (202 bp):
5’-AGAGTTGAAATCCAACA CC-3’ and 5’-TGGG
ACAGACGACTGA-3’; CYP17 (205 bp): 5’-GTGA
CCGTAA CCGTCT-3’ and 5’- ATGAACTGATCC
GGCT-3’; HSD3B2 (298 bp): 5’-CCATACCCGTA-
CAGCA-3’and 5’-AT TGACCTCGGACACT-3’;PEDADO1098_prT
E
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CYP19 (242 bp) 5’-CAGAGGCCAAGAGTTTGA
GG-3’ and 5’-ACACTAGCAGGTGGGTTTGG-3’;
b-actin (216 bp): 5’-AAGAGAGGCATCCTCACC
CT-3’ and 5’-TACATGGCTGG GGTGTTGAA-3’.
After an initial denaturation step of 94C for 4 min,
28 cycles were performed consisting of an initial de-
naturing step at 94C for 30s, followed by extension
at 60C for 30 s and elongation at 72C for 1 min.
Densitometric analysis of resulted PCR products re-
solved on a 2% agarose gel were quantified using
the AlphaEase FC software.
Results
Molecular Findings—Changes in the Gene
Expression of Steroidogenic Components in the
Maternal Ovary
As mentioned previously, it has been hypothesized
that vaginal secretions accumulate in response to cir-
culating maternal estrogens.4 In this study we also
sought to investigate this hypothesis by assessing
the gene expression of key steroidogenic enzymes
from the maternal ovary compared to age-matched
pooled controls. Semi-quantitative RT-PCR revealed
significant upregulation of the following genes when
compared to an age-matched normal ovary: StAR
by 1.55, CYP11A by 1.67, CYP17 by 7.1 and
CYP19 by 5.2 fold (Fig 1). The most profound in-
crease was that of CYP17 and CYP19 when compared
to the normal ovary, whereas the levels of 3bHSD2 re-
mained unaltered (data not shown). This is the first
study that we have found to describe a fetus with
hydrocolpos exhibiting changes in the expression of
maternal steroidogenic enzymes at the ovarian level.
Clinical Findings—Identification of Cystic Mass
and Hydronephrosis Using Ultrasound Scan and
Surgical Procedures
An abdominal cystic mass with maximum diameter
43.5 29.4 mm was discovered on a prenatal sono-
gram in a female fetus at 29 weeks gestation in
a 32-year-old woman para 1, gravida 3. Fetal biome-
try was within the normal range for gestational age.
The patient’s prenatal course, which included amnio-
paracentesis (because of patient’s family history for
trisomy 21 in a maternal aunt) had been uncompli-
cated and previous ultrasound scan examinations as
well as 21 weeks ultrasound scan were reported nor-
mal. Cytogenetic analysis revealed a normal female
karyotype (46 XX), and no chromosomal abnormali-
ties were detected. There was no history of familial
imperforate hymen. All serial prenatal ultrasound
scans were performed at a specialist fetal medicine
unit. On follow-up scans every 5e10 days, the ap-
pearance of the pelvic cystic mass showed a gradual
enlargement (Fig 2, panels a, b) and mild bilateraloof  09–11–2009 23:14:21
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Fig. 1. Changes in the gene expression of steroidogenic components in the maternal ovary. Lane 1: cDNA from normal ovaries;
Lane 2: cDNA from patient; Lane 3: negative control.
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Fig. 2. Panel a: Longitudinal view of the large cystic ab-
dominal mass with gravity dependent echoes, extending
up to the diaphragm at 33 5 weeks gestation. Panel b:
Transverse view at 33 5 weeks gestation reveals a large
cystic abdominal mass. Panel c: Sagittal view of bilateral
hydronephrosis, at 33 5 weeks gestation
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Fig. 3. A view of surgical hymenotomy performed by pedi-
atric surgeons.
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536Uhydronephrosis (Fig 2, panel c), but there were no
changes in amniotic fluid volume.
The patient was admitted to the hospital at 32
weeks because of premature uterine contractions and
corticosteroids were administered to prepare for even-
tual preterm birth as well as tocolytic therapy intrave-
nously (IV) to control contractions. At 35 weeks of
gestation the size of cystic mass increased, measuring
86 75 mm maximum and hydronephorsis worsened.PEDADO1098_prT
E
D
P
R
OUreteronephrosis was noticed while amniotic fluid
volume significantly increased (amniotic fluid index
(AFI) was 25e27 cm) followed by hydramnios
development. The estimated fetal weight was 3150 g.
Due to premature contractions and a history of pre-
vious cesarean section, the patient underwent an
emergency cesarean section and a female neonate
weighting 3250 g, at 35 weeks of pregnancy, with Ap-
gar scores of 8 and 9 after 1 and 5 minutes, respec-
tively, was delivered. The neonate was admitted to
the neonatal intensive care unit for ventilatory support
and further investigations. Physical examination
showed soft but distended mass above the umbilicus
abdomen measuring 8 7 cm.
Bladder catheterization was performed with
difficulty and clear urine was expressed. Renal func-
tion tests were normal at birth, with a creatinine of
0.7 mmol/L, and urea at 24 mmol/L. Abdominal ultra-
sound examination showed a cystic mass posterior to
the bladder, bilateral hydronephrosis (1.3 cm) and
hydroureter. MRI revealed an abdominal cystic mass
with maximal diameter 90 70 mm, which was felt
to be a hydrometrocolpos due to an imperforate
hymen.
Additional investigation of the urinary system dem-
onstrated normal kidneys, renal calyces, ureter, and
a small bladder displaced to the anterior abdominalwall
due to themass effect of the hydrocolpos.Neither reflux
nor ureteroceles were observed. The patient was re-
ferred to pediatric surgery. Consent was obtained from
the baby’s parents, and a hymenectomy was performed
where approximately 200 mL of clear serous and
mucoid fluid was drained (Figs 3 and 4).
Discussion
Congenital imperforate hymen is the most frequent
obstructive anomaly of the female genital tract. This
generally occurs sporadically, with a reportedoof  09–11–2009 23:14:21
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Fig. 4. View of tubing for drainage of retained secretions
trough vagina.
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incidence at term11 of 0.014e1% and gives rise to hy-
drometrocolpos in less than 1/16000 female births.12
Failure of this membrane to rupture results in congen-
ital imperforate hymen, which in combination with
accumulation of uterovaginal secretions, (produced
as a consequence of intrauterine stimulation of cervi-
cal mucous glands by maternal estrogen hormones),
may lead to the development of an internal hydrome-
trocolpos.13 This can be presented as a pelvic mass in
combination or not with urinary track obstruction and
oligohydramnios.
In this clinical case the cystic mass presented for the
first time during the 3rd trimester (29 weeks of gesta-
tion), having hypoechoic content with a maximum
diameter of 43.5 29.4 mm. At 35 weeks the cystic
mass had a maximum diameter of 86 75 mm causing
bilateral urinary obstruction and hydronephrosis. WhatU
N
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Fig. 5. Diagrammatic representation of steroid hormone biosynthe
that have been upregulated in the maternal ovary of the fetus wi
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is interesting and unique in our case is the fact that
although there was a lack of a normal urinary outlet,
oligohydramnios was not found. On the contrary, an
evident increase of the amniotic fluid volume (AFI,
25e27 cm) was observed. Cianciosi et al suggested
the following mechanisms for accompanied hydram-
nios in abdominal cystic masses: (a) the compression
of the adjacent bowel by the expanding cyst causing
a hypoperistaltic intestine, or reduction of the absorp-
tive capacity of the stomach and bowel by modifying
the gastrointestinal vascularization, and (b) the depres-
sion Qor an incorrect swallowing process, as suggested
by tongue protrusion, reducing the fluid removal from
the amniotic cavity.14
The differential diagnosis of imperforate hymen is
from labial adhesions, vaginal atresia, vaginal agene-
sis, and transverse vaginal septum. However, the ab-
dominal mass has to be diagnosed differentially
from distental urinary bladder, ovarian tumors and
neoplasms, mesenteric cysts, anterior meningoceles,
reduplication of sigmoid and sacral tumors. Prenatal
ultrasonographic diagnosis of hydrocolpos has only
been reported in three cases,7,15,16 none of which
had hydramnios detected.
As mentioned previously, it has been hypothesized
that vaginal secretions accumulate in response to
circulating maternal estrogens.4 Therefore, based on
our observations from the gene expression studies, it
is attractive to speculate that, in this particular clinical
case of hydrocolpos, the overall steroidogenic activity
in the maternal ovary would have been enhanced. In-
deed, when compared to control patients, the largest
increase in gene expression was that of CYP17 and
CYP19. CYP17 is expressed in all classic steroido-
genic organs and in the human ovary it is selectivelyQ5
sis steps in the human ovary. In red Q6are the key components
th hydrocolpos.
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expressed in thecal cells.17 CYP19, on the other hand,
has a far wider distribution and in the human ovary is
primarily expressed in the corpus luteum. This is of
particular importance to this case because CYP19
catalyzes reactions leading to estrogen biosynthesis.
Depending on its expression, CYP19 (P450arom)
catalyzes the conversion of the C19 androgens, an-
drostenedione and testosterone, to the C18 estrogens,
estrone and estradiol, respectively.17
It is well known that steroids such as maternal
estrogens as well as progesterone rise exponentially
during the later stages in pregnancy.What is interesting
in this clinical case is that the control ovarian samples
were also taken from age-matched women, undergoing
cesarean section. As a result, it is the possible dysregu-
lation of the maternal steroidogenic pathway in this
clinical case that might contribute to the upregulation
of certain enzymes. In addition, with regard to a link be-
tween types of circulating estrogens and polyhydram-
nios, very little is known. However, a study by Phocas
et al showed that therewas a discrepancy in the estrogen
levels regarding their increase. This was due to the type
polyhydramnios, the pregnancy outcome, and the
condition of fetus at birth.18
In conclusion, this is a novel clinical casewhere there
is clear evidence of a maternal steroidogenic over-drive
associated with fetal hydrocolpos, thus potentially link-
ing maternal ovarian steroidal stimulation with this
pathophysiological condition.
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